Press Releases :: CV Sciences, Inc. (CVSI)

Investors

Investors

CV Sciences is a consumer wellness company specializing in nutraceuticals and plant-based foods.

Press Releases

CV Sciences, Inc. Reports Third Quarter 2024 Financial Results

Nov 14, 2024

CV Sciences, Inc. To Announce Third Quarter 2024 Results On November 14, 2024

Nov 8, 2024

CV Sciences Launches +PlusHLTH, a New Line of Cannabinoid-Free Supplements

Aug 27, 2024

CV Sciences, Inc. Reports Second Quarter 2024 Financial Results

Aug 13, 2024

CV Sciences, Inc. To Announce Second Quarter 2024 Results On August 13, 2024

Aug 7, 2024

CV Sciences, Inc. Reports First Quarter 2024 Financial Results

May 14, 2024

CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER

May 13, 2024

CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024

May 8, 2024

CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results

Mar 28, 2024

CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews

Mar 26, 2024